List of Tables
Table 1. Plasma Derived Medicine Market Trends
Table 2. Plasma Derived Medicine Market Drivers & Opportunity
Table 3. Plasma Derived Medicine Market Challenges
Table 4. Plasma Derived Medicine Market Restraints
Table 5. Global Plasma Derived Medicine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Plasma Derived Medicine Revenue Market Share by Company (2019-2024)
Table 7. Global Plasma Derived Medicine Sales Volume by Company (2019-2024) & (K Bottles)
Table 8. Global Plasma Derived Medicine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Plasma Derived Medicine Price by Company (2019-2024) & (USD/Bottle)
Table 10. Key Manufacturers Plasma Derived Medicine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Plasma Derived Medicine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Plasma Derived Medicine
Table 13. Global Plasma Derived Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plasma Derived Medicine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Plasma Derived Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Plasma Derived Medicine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Plasma Derived Medicine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Plasma Derived Medicine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Plasma Derived Medicine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Plasma Derived Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Bottles)
Table 22. Global Plasma Derived Medicine Sales Volume by Type (2019-2024) & (K Bottles)
Table 23. Global Plasma Derived Medicine Sales Volume by Type (2025-2030) & (K Bottles)
Table 24. Global Plasma Derived Medicine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Plasma Derived Medicine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Plasma Derived Medicine Price by Type (2019-2024) & (USD/Bottle)
Table 27. Global Plasma Derived Medicine Price by Type (2025-2030) & (USD/Bottle)
Table 28. Global Plasma Derived Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Plasma Derived Medicine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Plasma Derived Medicine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Plasma Derived Medicine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Plasma Derived Medicine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Plasma Derived Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Bottles)
Table 34. Global Plasma Derived Medicine Sales Volume by Application (2019-2024) & (K Bottles)
Table 35. Global Plasma Derived Medicine Sales Volume by Application (2025-2030) & (K Bottles)
Table 36. Global Plasma Derived Medicine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Plasma Derived Medicine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Plasma Derived Medicine Price by Application (2019-2024) & (USD/Bottle)
Table 39. Global Plasma Derived Medicine Price by Application (2025-2030) & (USD/Bottle)
Table 40. Global Plasma Derived Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Plasma Derived Medicine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Plasma Derived Medicine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Plasma Derived Medicine Sales Value by Region (2019-2024) & (%)
Table 44. Global Plasma Derived Medicine Sales Value by Region (2025-2030) & (%)
Table 45. Global Plasma Derived Medicine Sales Volume by Region (K Bottles): 2019 VS 2023 VS 2030
Table 46. Global Plasma Derived Medicine Sales Volume by Region (2019-2024) & (K Bottles)
Table 47. Global Plasma Derived Medicine Sales Volume by Region (2025-2030) & (K Bottles)
Table 48. Global Plasma Derived Medicine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Plasma Derived Medicine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Plasma Derived Medicine Average Price by Region (2019-2024) & (USD/Bottle)
Table 51. Global Plasma Derived Medicine Average Price by Region (2025-2030) & (USD/Bottle)
Table 52. Key Countries/Regions Plasma Derived Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Plasma Derived Medicine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Plasma Derived Medicine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Plasma Derived Medicine Sales Volume, (2019-2024) & (K Bottles)
Table 56. Key Countries/Regions Plasma Derived Medicine Sales Volume, (2025-2030) & (K Bottles)
Table 57. Takeda Company Information
Table 58. Takeda Introduction and Business Overview
Table 59. Takeda Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 60. Takeda Plasma Derived Medicine Product Offerings
Table 61. Takeda Recent Development
Table 62. CSL Company Information
Table 63. CSL Introduction and Business Overview
Table 64. CSL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 65. CSL Plasma Derived Medicine Product Offerings
Table 66. CSL Recent Development
Table 67. Grifols Company Information
Table 68. Grifols Introduction and Business Overview
Table 69. Grifols Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 70. Grifols Plasma Derived Medicine Product Offerings
Table 71. Grifols Recent Development
Table 72. Octapharma Company Information
Table 73. Octapharma Introduction and Business Overview
Table 74. Octapharma Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 75. Octapharma Plasma Derived Medicine Product Offerings
Table 76. Octapharma Recent Development
Table 77. Kedrion Company Information
Table 78. Kedrion Introduction and Business Overview
Table 79. Kedrion Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 80. Kedrion Plasma Derived Medicine Product Offerings
Table 81. Kedrion Recent Development
Table 82. LFB Group Company Information
Table 83. LFB Group Introduction and Business Overview
Table 84. LFB Group Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 85. LFB Group Plasma Derived Medicine Product Offerings
Table 86. LFB Group Recent Development
Table 87. Biotest Company Information
Table 88. Biotest Introduction and Business Overview
Table 89. Biotest Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 90. Biotest Plasma Derived Medicine Product Offerings
Table 91. Biotest Recent Development
Table 92. BPL Company Information
Table 93. BPL Introduction and Business Overview
Table 94. BPL Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 95. BPL Plasma Derived Medicine Product Offerings
Table 96. BPL Recent Development
Table 97. Shanghai RAAS Company Information
Table 98. Shanghai RAAS Introduction and Business Overview
Table 99. Shanghai RAAS Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 100. Shanghai RAAS Plasma Derived Medicine Product Offerings
Table 101. Shanghai RAAS Recent Development
Table 102. China Biologic Products Company Information
Table 103. China Biologic Products Introduction and Business Overview
Table 104. China Biologic Products Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 105. China Biologic Products Plasma Derived Medicine Product Offerings
Table 106. China Biologic Products Recent Development
Table 107. Hualan Biological Engineering Inc. Company Information
Table 108. Hualan Biological Engineering Inc. Introduction and Business Overview
Table 109. Hualan Biological Engineering Inc. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 110. Hualan Biological Engineering Inc. Plasma Derived Medicine Product Offerings
Table 111. Hualan Biological Engineering Inc. Recent Development
Table 112. Beijing Tiantan Biological Products Corp Company Information
Table 113. Beijing Tiantan Biological Products Corp Introduction and Business Overview
Table 114. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 115. Beijing Tiantan Biological Products Corp Plasma Derived Medicine Product Offerings
Table 116. Beijing Tiantan Biological Products Corp Recent Development
Table 117. Pacific Shuanglin Company Information
Table 118. Pacific Shuanglin Introduction and Business Overview
Table 119. Pacific Shuanglin Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 120. Pacific Shuanglin Plasma Derived Medicine Product Offerings
Table 121. Pacific Shuanglin Recent Development
Table 122. Boya Bio-Pharmaceutical Company Information
Table 123. Boya Bio-Pharmaceutical Introduction and Business Overview
Table 124. Boya Bio-Pharmaceutical Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 125. Boya Bio-Pharmaceutical Plasma Derived Medicine Product Offerings
Table 126. Boya Bio-Pharmaceutical Recent Development
Table 127. Paisi Feike Biology Pharmacy Co., Ltd. Company Information
Table 128. Paisi Feike Biology Pharmacy Co., Ltd. Introduction and Business Overview
Table 129. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 130. Paisi Feike Biology Pharmacy Co., Ltd. Plasma Derived Medicine Product Offerings
Table 131. Paisi Feike Biology Pharmacy Co., Ltd. Recent Development
Table 132. Xinjiang Deyuan Bioengineering Company Information
Table 133. Xinjiang Deyuan Bioengineering Introduction and Business Overview
Table 134. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 135. Xinjiang Deyuan Bioengineering Plasma Derived Medicine Product Offerings
Table 136. Xinjiang Deyuan Bioengineering Recent Development
Table 137. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Company Information
Table 138. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 139. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 140. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma Derived Medicine Product Offerings
Table 141. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Development
Table 142. Shenzhen Weiguang Company Information
Table 143. Shenzhen Weiguang Introduction and Business Overview
Table 144. Shenzhen Weiguang Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 145. Shenzhen Weiguang Plasma Derived Medicine Product Offerings
Table 146. Shenzhen Weiguang Recent Development
Table 147. Shanxi Kangbao Company Information
Table 148. Shanxi Kangbao Introduction and Business Overview
Table 149. Shanxi Kangbao Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 150. Shanxi Kangbao Plasma Derived Medicine Product Offerings
Table 151. Shanxi Kangbao Recent Development
Table 152. Nanyue Biopharming Corporation Ltd Company Information
Table 153. Nanyue Biopharming Corporation Ltd Introduction and Business Overview
Table 154. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Sales (K Bottles), Revenue (US$ Million), Price (USD/Bottle) and Gross Margin (2019-2024)
Table 155. Nanyue Biopharming Corporation Ltd Plasma Derived Medicine Product Offerings
Table 156. Nanyue Biopharming Corporation Ltd Recent Development
Table 157. Key Raw Materials Lists
Table 158. Raw Materials Key Suppliers Lists
Table 159. Plasma Derived Medicine Downstream Customers
Table 160. Plasma Derived Medicine Distributors List
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Plasma Derived Medicine Product Picture
Figure 2. Global Plasma Derived Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Plasma Derived Medicine Sales Volume (2019-2030) & (K Bottles)
Figure 5. Global Plasma Derived Medicine Sales Price (2019-2030) & (USD/Bottle)
Figure 6. Plasma Derived Medicine Report Years Considered
Figure 7. Global Plasma Derived Medicine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Plasma Derived Medicine Players Sales Volume Ranking (2023) & (K Bottles)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Plasma Derived Medicine Revenue in 2023
Figure 10. Plasma Derived Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Albumin Picture
Figure 12. Immune Globulin Picture
Figure 13. Coagulation Factor Picture
Figure 14. Others Picture
Figure 15. Global Plasma Derived Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Plasma Derived Medicine Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Plasma Derived Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Bottles)
Figure 18. Global Plasma Derived Medicine Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Plasma Derived Medicine Price by Type (2019-2030) & (USD/Bottle)
Figure 20. Product Picture of Bleeding Wound
Figure 21. Product Picture of Immunodeficiency
Figure 22. Product Picture of HBV
Figure 23. Product Picture of Tetanus
Figure 24. Product Picture of Rabies
Figure 25. Product Picture of Hemophilia
Figure 26. Product Picture of Others
Figure 27. Global Plasma Derived Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Plasma Derived Medicine Sales Value Market Share by Application, 2023 & 2030
Figure 29. Global Plasma Derived Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Bottles)
Figure 30. Global Plasma Derived Medicine Sales Volume Market Share by Application, 2023 & 2030
Figure 31. Global Plasma Derived Medicine Price by Application (2019-2030) & (USD/Bottle)
Figure 32. North America Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
Figure 33. North America Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
Figure 34. Europe Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
Figure 35. Europe Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
Figure 36. Asia Pacific Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
Figure 38. South America Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
Figure 39. South America Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
Figure 40. Middle East & Africa Plasma Derived Medicine Sales Value (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Plasma Derived Medicine Sales Value by Country (%), 2023 VS 2030
Figure 42. Key Countries/Regions Plasma Derived Medicine Sales Value (%), (2019-2030)
Figure 43. Key Countries/Regions Plasma Derived Medicine Sales Volume (%), (2019-2030)
Figure 44. United States Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 45. United States Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
Figure 46. United States Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
Figure 47. Europe Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 48. Europe Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
Figure 49. Europe Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
Figure 50. China Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 51. China Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
Figure 52. China Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
Figure 53. Japan Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 54. Japan Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
Figure 55. Japan Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
Figure 56. South Korea Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 57. South Korea Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
Figure 58. South Korea Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
Figure 59. Southeast Asia Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 60. Southeast Asia Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
Figure 61. Southeast Asia Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
Figure 62. India Plasma Derived Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 63. India Plasma Derived Medicine Sales Value by Type (%), 2023 VS 2030
Figure 64. India Plasma Derived Medicine Sales Value by Application (%), 2023 VS 2030
Figure 65. Plasma Derived Medicine Industrial Chain
Figure 66. Plasma Derived Medicine Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
